MITA Congratulates Dr. Scott Gottlieb on Nomination as FDA Commissioner


MITA Congratulates Dr. Scott Gottlieb on Nomination as FDA Commissioner

Washington, D.C. – Today, the Medical Imaging & Technology Alliance (MITA) issued the following statement from Executive Director Patrick Hope:

“MITA congratulates Dr. Scott Gottlieb on his nomination as the 23rd Commissioner of the Food and Drug Administration (FDA), which plays a critical role in assuring the quality and safety of medical imaging equipment. We look forward to working with Dr. Gottlieb to ensure patients have access to the safest and most advanced medical imaging technologies.”

The Medical Imaging & Technology Alliance (MITA), a division of NEMA, is the collective voice of medical imaging equipment, radiation therapy and radiopharmaceutical manufacturers, innovators and product developers. It represents companies whose sales comprise more than 90 percent of the global market for advanced medical imaging. For more information, visit Follow MITA on Twitter @MITAToday.

  • Imaging Forward

    In just 20 years, medical imaging has dramatically improved health outcomes and lowered costs. Imagine what the future holds. Learn More

  • MITA Smart Initiative

    Promoting patient safety and enhancing the quality of medical imaging technology with MITA Smart Standards. Learn More

  • Fluoro Pharma

    Why I Joined MITA – FluoroPharma Medical, Inc.

    Hear from Thomas Tulip, Ph.D, President, FluoroPharma Medical, Inc. on why his organization joined MITA.

    Learn More